Zobrazeno 1 - 10
of 318
pro vyhledávání: '"Young Rok, Do"'
Autor:
Jongheon Jung, Sung-Hoon Jung, Je-Jung Lee, Young Rok Do, Ka-Won Kang, Jung Lim Lee, Sung-Soo Yoon, Chang-Ki Min, Hye Jin Kang, Ji Hyun Lee, Ju-Hyun Park, Kihyun Kim, Hyeon-Seok Eom, The Korean Multiple Myeloma Working Party (KMMWP)
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Tandem autologous stem cell transplantation can improve the prognosis of patients with multiple myeloma. However, the precise role of tandem transplantation remains debatable. We evaluated the clinical benefits of tandem transplantation retr
Externí odkaz:
https://doaj.org/article/5ee6223318964fd084fe2b2b29a41069
Autor:
Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong Kwak
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 3, Pp 501-512 (2024)
Background/Aims Optimal risk stratification based on simplified geriatric assessment to predict treatment-related toxicity and survival needs to be clarified in older patients with diffuse large B-cell lymphoma (DLBCL). Methods This multicenter prosp
Externí odkaz:
https://doaj.org/article/776c9c0704b945f3bb578ac1fc298d96
Autor:
Changhee Park, Ho Sup Lee, Ka-Won Kang, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok-Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung-Soo Yoon, Youngil Koh
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-11 (2024)
Abstract Potential synergism between Bruton’s tyrosine kinase (BTK) inhibitor and lenalidomide in treating aggressive B-cell lymphoma has been suggested. Here, the authors report a single-arm phase II clinical trial of combination of acalabrutinib,
Externí odkaz:
https://doaj.org/article/1be364a2c8774becbc1348fb645041c5
Autor:
Ji Hyun Lee, Jimin Choi, Chang-Ki Min, Sung-Soo Park, Jae-Cheol Jo, Yoo Jin Lee, Jin Seok Kim, Hyeon-Seok Eom, Jongheon Jung, Joon Ho Moon, Hee Jeong Cho, Myung-won Lee, Sung-Soo Yoon, Ja Min Byun, Jae Hoon Lee, Je-Jung Lee, Sung-Hoon Jung, Ho-Jin Shin, Do Young Kim, Jun Ho Yi, Seung-Shin Lee, Young Rok Do, Dok Hyun Yoon, Hyungwoo Cho, Won Sik Lee, Ho Sup Lee, Jieun Uhm, Hyo Jung Kim, Hee Ryeong Jang, Sung-Hyun Kim, Kihyun Kim
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Carfilzomib, lenalidomide, and dexamethasone (KRd) combination therapy improves the survival of patients with relapsed and/or refractory multiple myeloma (RRMM). Nonetheless, evidence on the use of KRd in Asian populations remains scarce. Accordingly
Externí odkaz:
https://doaj.org/article/064da959c7a04a2988554e9f91efe087
Autor:
Dong Won Baek, Han-Seung Park, Sang Kyun Sohn, Dae Young Kim, Inho Kim, Jae-Sook Ahn, Young Rok Do, Se Ryeon Lee, Hyeon-Seok Eom, Won-Sik Lee, Sung-Hyun Kim, Ho Sup Lee, Yoo Jin Lee, Joon Ho Moon, Je-Hwan Lee, Adult Acute Lymphoblastic Leukemia Working Party, the Korean Society of Hematology
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 5, Pp 734-746 (2023)
Background/Aims We performed a prospective study to determine the efficacy and safety of rituximab including chemotherapy in CD20-positive acute lymphoblastic leukemia (ALL). Methods Patients with newly diagnosed ALL, aged ≥ 15 years, were eligible
Externí odkaz:
https://doaj.org/article/35144df3d4e9443393e6fddb24e41b02
Autor:
Dong Won Baek, Ga-Young Song, Ho Sup Lee, Young Rok Do, Ji Hyun Lee, Ho-Young Yhim, Joon Ho Moon, Deok-Hwan Yang
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundElderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergoing reduced intensity R-CHOP therapy are at a heightened risk of acquiring infections, notably coronavirus disease 2019 (COVID-19) infection. This study aimed to e
Externí odkaz:
https://doaj.org/article/e7eeb709b17e4c8399edb188a80e5353
Autor:
Yu Ri Kim, Ho Jin Shin, Ho-Young Yhim, Deok-Hwan Yang, Yong Park, Ji Hyun Lee, Won-Sik Lee, Young Rok Do, Yeung-Chul Mun, Dae Sik Kim, Jin Seok Kim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundBone marrow (BM) involvement is an indicator of a poor prognosis in diffuse large B-cell lymphoma (DLBCL); however, few studies have evaluated the role of immunoglobulin gene rearrangement (IgR) in detecting BM involvement.MethodsWe evaluat
Externí odkaz:
https://doaj.org/article/45cd96a278aa4d918d0f215ef45bf304
Autor:
Hyungwoo Cho, Kihyun Kim, Sang Eun Yoon, Sung‐Hoon Jung, Je‐Jung Lee, Joon Ho Moon, Hee Jeong Cho, Ho Sup Lee, Ka‐Won Kang, Sung‐Yong Kim, Hyeon‐Seok Eom, Yeung‐Chul Mun, Young Hoon Park, Sung‐Soo Yoon, Young Rok Do, Won Sik Lee, Chang‐Ki Min, Dok Hyun Yoon
Publikováno v:
HemaSphere, Vol 8, Iss 1, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/83f0181575af46f6b195657a752b4626
Autor:
Eun Hee Jung, Ja Min Byun, Dong‐Yeop Shin, Young Rok Do, Jae‐Cheol Jo, Sang Min Lee, Sung‐Soo Yoon
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9186-9193 (2023)
Abstract Background Current guidelines recommend using filgrastim or tbo‐filgrastim to mobilize hematopoietic progenitor cells in an autologous setting. However, previous studies have suggested other forms of granulocyte colony‐stimulating factor
Externí odkaz:
https://doaj.org/article/8c228b955fc042649b3dd11e4eb9306c
Autor:
Hee Jeong Cho, Jae-Cheol Jo, Yoo Jin Lee, Myung Won Lee, Do Young Kim, Ho Jin Shin, Sung Nam Im, Ji Hyun Lee, Sung Hwa Bae, Young Rok Do, Won Sik Lee, Min Kyung Kim, Jina Jung, Jung Min Lee, Ju-Hyung Kim, Dong Won Baek, Sang-Kyun Sohn, Joon Ho Moon
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 2, Pp 238-247 (2023)
Background/Aims Daratumumab has shown an encouraging antitumor effect in patients with multiple myeloma (MM), and was known to alter the immune properties by off-targeting immunosuppressive cells. Here, we aimed to evaluate the change in absolute lym
Externí odkaz:
https://doaj.org/article/ae24d4e0897248d2a9eeeb9acb663e6d